Management of uveitis

Clinical and Experimental Medicine

Volumn 4, Issue 1, 2004, Pages 21-29

  Smith, J R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Diagnosis; Immunosuppression; Systemic disease; Treatment; Uveitis

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CD52 ANTIBODY; CIDOFOVIR; COBALT; CORTICOSTEROID; CYCLOPENTOLATE; CYCLOSPORIN; DIETHYLCARBAMAZINE; FLUOCINOLONE ACETONIDE; GAMMA INTERFERON; HOMATROPINE; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL CONTRACEPTIVE AGENT; PAMIDRONIC ACID; PREDNISONE; QUINIDINE; RIFABUTIN; STREPTOKINASE; SULFACETAMIDE; SULFONAMIDE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BONE MARROW TOXICITY; CATARACT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DRUG COST; DRUG DELIVERY SYSTEM; EYE INFECTION; EYE SURGERY; FEMALE STERILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTERSTITIAL PNEUMONIA; INTRAOCULAR HYPERTENSION; LABORATORY DIAGNOSIS; LIVER TOXICITY; LOW DRUG DOSE; LUPUS VULGARIS; MALE STERILITY; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TREATMENT PLANNING; TUBERCULOSIS; UVEITIS; VISUAL DISORDER;

HUMANS; PROGNOSIS; UVEITIS;

EID: 4644225965     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-004-0034-3     Document Type: Review

References (55)

1. Darrell RW, Wagener HP, Kurland LT (1962) Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 68:502-514
2. Saari KM, Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, Sillanpaa M (1995) Epidemiology of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand 73:345-349
3. Dandona L, Dandona R, John RK, McCarty CA, Rao GN (2000) Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol 84:706-709
4. Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103:234-235
5. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG (1996) Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121:35-46
6. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D'Amico DJ, Foster CS (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114:593-599
7. Smith JR (2002) HLA-B27-associated uveitis. Ophthalmol Clin North Am 15:297-307
8. Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61-64
9. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT (2000) Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 59:67-70
10. Petty RE, Smith JR, Rosenbaum JT (2003) Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol 135:879-884
11. Holland GN, Stiehm ER (2003) Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol 135:867-878
12. Petty RE and the Task Force for Classification Criteria (1998) Revision for the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991-1994
13. American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology (1993) Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 92:295-296
14. Lim JI, Tessler HH, Goodwin JA (1991) Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology 98:142-145
15. Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195-208
16. Dobrin RS, Vernier RL, Fish AL (1975) Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med 59:325-333
17. Jones NP (1993) Fuchs' heterochromic uveitis: an update. Surv Ophthalmol 37:253-272
18. Siverio Junior CD, Imai Y, Cunningham ET Jr (2002) Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin 42:43-48
19. Dougados M, Berenbaum F, Maetzel A, Amor B (1993) Prevention of acute anterior uveitis associated with spondyloarthropathy induced by salazosulfapyridine. Rev Rhum Fr Ed 60:81-83
20. Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Banares A (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14:340-343
21. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, Nussenblatt RB, Stiehm ER, Tessler H, Van Gelder RN, Whitcup SM, Yocum D (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492-513
22. Gion N, Stavrou P, Foster CS (2000) Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis. Am J Ophthalmol 129:764-768
23. Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM (2002) An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 86:51-56
24. Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, Bressler NM (1999) Pars planitis: clinical features and class II HLA associations. Ophthalmology 106:594-599
25. Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM (2001) Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 9:93-102
26. Lauer AK, Smith JR, Robertson JE, Rosenbaum JT (2002) Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology 109:95-98
27. Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100:818-824
28. Hovakimyan A, Cunningham ET Jr (2002) Ocular toxoplasmosis. Ophthalmol Clin North Am 15:327-332
29. Holland GN (1999) Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 128:502-505
30. Duker JS, Blumenkranz MS (1991) Diagnosis and management of the acute retinal necrosis (ARN) syndrome. Surv Ophthalmol 35:327-343
31. Knox CM, Chandler D, Short GA, Margolis TP (1998) Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis. Use in diagnostic dilemmas. Ophthalmology 105:37-44
32. Holland GN (1994) The progressive outer retinal necrosis syndrome. Int Ophthalmol 18:163-165
33. Rosenbaum JT, Robertson JE Jr, Watzke RC (1991) Retinal vasculitis - a primer. West J Med 154:182-185
34. Polk TD, Goldman EJ (1999) White-dot chorioretinal inflammatory syndromes. Int Ophthalmol Clin 39:33-53
35. Brown J Jr, Folk JC (1998) Current controversies in the white dot syndromes. Multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ocul Immunol Inflamm 6:125-127
36. Rothova A (2000) Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110-116
37. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Current concepts: Behcet's disease. N Engl J Med 341:1284-1291
38. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647-652
39. Chu DS, Foster CS (2002) Sympathetic ophthalmia. Int Ophthalmol Clin 42:179-185
40. Myllykangas-Luosujarvi R, Aho K, Isomaki H (1995) Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol 22:2200-2202
41. Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P (2000) Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology 107:2024-2033
42. Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB (2000) Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet Immunol Immunopathol 76:239-255
43. Halhal M, Renard G, Bejjani RA, Behar-Cohen F (2003) Rejet de greffe et iontophorèse de corticoïdes: à propos de 3 cas. J Fr Ophtalmol 26:391-395
44. Young S, Larkin G, Branley M, Lightman S (2001) Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis, Clin Exp Ophthalmol 29:2-6
45. Rosenbaum JT, Smith JR (2002) Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 20:S143-S145
46. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 358:295-296
47. El-Shabrawi Y, Hermann J (2002) Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 109:2342-2346
48. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45:252-257
49. Kotter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Gunaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stubiger N (2003) Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423-431
50. Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM (1999) Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci USA 96:7462-7466
51. Dick AD, Meyer P, James T, Forrester JV, Hale G, Waldmann H, Isaacs JD (2000) Campath-1H therapy in refractory ocular inflammatory disease. Br J Ophthalmol 84:107-109
52. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332-336
53. Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM (2001) Uveitis masquerade syndromes. Ophthalmology 108:386-399
54. Fraunfelder FW, Rosenbaum JT (1997) Drug-induced uveitis. Incidence, prevention and treatment. Drug Saf 17:197-207
55. Tabbara KF (2000) Infectious uveitis: a review. Arch Soc Esp Oftalmol 75:215-259